Research ArticlePotential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease
Introduction
The incidence of non-alcoholic fatty liver disease (NAFLD) is increasing dramatically across the Western World, becoming the commonest cause for incidental abnormal liver function tests, affecting up to 30% of the population [1], [2], [3], [4]. At present, treatment options are limited and pharmacological management of NAFLD has had disappointing results [5]. Some of the best available evidence to improve NAFLD (normalisation of serum liver transaminases, reversal of hepatic steatosis or inflammation) concerns lifestyle modification [6]. NAFLD subjects have suboptimal cardio respiratory fitness, muscle strength and physical activity participation and are encouraged to exercise in order to improve their disease [7]. In general, implementation of dietary advice and/or exercise as a treatment are poor as evidenced by clinical experience and high drop out rates from trials [8], [9], [10]. The available evidence concerning reasons for dropping out of exercise-based treatments is rather scanty. Encouraging self-efficacy has been implicated as one of the most important strategies to engage NAFLD subjects in lifestyle modification [11].
Self-efficacy expectations are an individual’s judgement of confidence to carry out specific behaviours [12]. Confidence determines whether an individual chooses to perform exercise, the effort they invest and the length of time they will continue to exercise [13]. Expectations are beliefs that beneficial results will be produced by performing exercise [14], [15]. In addition to confidence and expectation, a fear of falling also strongly influences engagement in physical activity, with greater levels of fear strongly correlating with the levels of exercise performed [16]. As physical activity is encouraged in patients with NAFLD we thought it crucial to address confidence, expectations of exercise and fear of falling in this population, to understand further how to improve implementation and concordance.
Section snippets
Study populations
NAFLD: Participants were identified from a large, continuously updated cohort of consecutive patients attending the Newcastle Tertiary Liver Clinic, with a histological diagnosis of NAFLD. All subjects gave fully informed consent for data storage and for research. The diagnosis of NAFLD was based on the following criteria: (1) elevated aminotransferases (AST and/or ALT); (2) liver biopsy showing steatosis in at least 10% of hepatocytes; and (3) appropriate exclusion of liver disease of other
Demographics
Details of response rates, age, BMI, and disease severity are displayed in Table 1. Of the NAFLD participants 41% (n = 94) had simple steatosis, 44.3% (n = 102) had NASH and 15% (n = 34) had cirrhotic NAFLD.
Confidence to exercise
In the NAFLD participants the median confidence level was 0.0 (range 0.0–10.0). In the control groups the median score for ALD was 0.0 (range 0.0–10.0) and in the PBC group the median score was 4.5 (0.0–10.0). The difference in medians across all the groups was highly significant (p < 0.001). When
Discussion
In this large, cross-sectional analysis of subjective concerns related to exercise in participants with chronic liver disease, we demonstrate a widespread, low confidence to perform physical activity. This finding is particularly pertinent to those with NAFLD where physical activity is often encouraged as a treatment option. In comparison to our control groups, those with ALD also show low confidence to perform physical activity at a similar level to those with NAFLD. Interestingly our PBC
Acknowledgements
The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.
References (29)
- et al.
Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology
J Hepatol
(2001) - et al.
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
J Hepatol
(2005) - et al.
Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease
Hepatology
(2003) - et al.
Valine–alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis
Hepatology
(2002) - et al.
Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease
Free Radic Biol Med
(2002) - et al.
The true impact of fatigue in primary biliary cirrhosis: a population study [see comment]
Gastroenterology
(2002) - et al.
Familial primary biliary cirrhosis reassessed: a geographically-based population study
J Hepatol
(1999) - et al.
Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use
J Hepatol
(2000) - et al.
Prevalence of and risk factors for hepatic steatosis in Northern Italy
Ann Intern Med
(2000) - et al.
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
Hepatology
(2004)
Prevalence of and risk factors for non-alcoholic fatty liver disease: the Dionysos nutrition and liver study
Hepatology
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
Cochrane Database Syst Rev
Benefits of lifestyle modification in NAFLD
Gut
Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease [see comment]
Hepatology
Cited by (80)
Barriers and Facilitators to Mediterranean Diet Adoption by Patients With Nonalcoholic Fatty Liver Disease in Northern Europe
2019, Clinical Gastroenterology and HepatologyEpidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
2020, Annals of HepatologyCitation Excerpt :In severely obese patients with coexisting MetS features the prevalence of imaging-defined NAFLD is approximately 90–95% and more than one third of these patients have NASH on histology [20]. Indeed, increased values of BMI and waist circumference are not only associated with the presence of NAFLD [21], but also with an increased risk of liver disease progression, especially in older patients [22,23]. This may partly due to the fact that NAFLD is more strongly associated with visceral fat than subcutaneous fat [24–27].
Research progress on exercise adherence in patients with metabolic associated fatty liver disease
2024, Chinese Journal of Health ManagementHigh-intensity Interval Training for the Management of Nonalcoholic Steatohepatitis: Participant Experiences and Perspectives
2023, Journal of Clinical and Translational Hepatology